Pms-Bortezomib 3.5 mg (Bortezomib (Bortezomib Mannitol Boronic Ester) POWDER FOR SOLUTION) 3.5 MG

PMS-Bortezomib 3.5 mg is a powder for solution used for intravenous administration. It contains the active ingredient bortezomib, a medication often associated with cancer treatment. This product is manufactured by Pharmascience Inc. in Canada.

Strength

3.5 MG

Manufacturer / TM Owner

PHARMASCIENCE INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

PMS-Bortezomib 3.5 mg is primarily used in the management of certain types of cancer. It works by targeting specific proteins in the body to help slow down or stop the growth of cancer cells. The medication is often prescribed as part of a broader treatment plan, which may include other therapies. Patients should consult their healthcare provider to understand the specific uses of bortezomib in their treatment regimen.

Side Effects

Common effects of PMS-Bortezomib 3.5 mg may include fatigue, nausea, and peripheral neuropathy. Some patients may experience changes in blood cell counts, which can lead to increased susceptibility to infections or bleeding. It is important to monitor for any unusual symptoms and report them to a healthcare professional.

Precautions & Warnings

PMS-Bortezomib 3.5 mg should be handled with care, as it is a potent medication. It is essential to follow the preparation and administration instructions provided by a healthcare professional. Patients with a history of certain medical conditions, such as liver or kidney disease, should inform their healthcare provider before starting treatment. Proper storage and disposal of the medication are crucial to ensure safety.

Avoid Interactions

PMS-Bortezomib 3.5 mg may interact with other medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and certain foods may also affect the efficacy of bortezomib, so it is advisable to discuss any dietary restrictions with your healthcare provider.

Frequently Asked Questions

PMS-Bortezomib 3.5 mg is used in the management of certain types of cancer, often as part of a broader treatment plan.

PMS-Bortezomib 3.5 mg is administered intravenously after being reconstituted as a solution. A healthcare professional will provide specific instructions for preparation and administration.

Common side effects may include fatigue, nausea, and peripheral neuropathy. Patients should report any unusual symptoms to their healthcare provider.

Yes, PMS-Bortezomib 3.5 mg may interact with other medications, especially those that affect liver enzymes. Always inform your healthcare provider about all medications you are taking.

Precautions include following the preparation and administration instructions provided by a healthcare professional and informing your provider about any medical conditions or other medications you are taking.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.